Larry Magid: Testing prescription, over-the-counter continuous glucose monitors
A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...
Abbott banks on glucose monitors, new launches to ride out China, currency hit
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more ...
Expanding EPD Business Supports ABT Stock Amid Macro Issues
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
pharmaphorum8d
Real-time Abbott glucose monitor available to NHS after UK launch
The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...
The Motley Fool: A diverse health care dynamo
Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...
Motley Fool: A health care dynamo
Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...
Why Is Abbott Stock Trading Higher On Thursday?
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.
Abbott Laboratories: Evercore ISI Raises Valuation on Strong Q4
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Morningstar29d
Abbott Seeks to Expand Its Libre Glucose Monitor Franchise Well Beyond Diabetes Patients
In our view, Abbott's FreeStyle Libre blood glucose monitor franchise ... surgical heart valves, continuous glucose monitors, coronary stents, venous closure, and immunoassays.